Chicory Root Fiber Constipation Randomized Trial: What the Evidence Says
Chicory Root Fiber Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first
Quick Answer
Chicory Root Fiber Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 2 research article.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Chicory Root Fiber Constipation Randomized Trial: What the Evidence Says
Quick Answer
Chicory Root Fiber Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults | research article | 4 | 2026-01-01 | 10.20517/mrr.2026.04 |
| Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation | research article | 4 | 2025-11-24 | 10.3390/nu17233674 |
What The Sources Report
- High diversity of the gut microbiota has been associated with a reduced risk of developing non-communicable diseases, and a varied diet with an assortment of different fibers can support gut microbiota diversity. [Kerezoudi Evangelia N. (2026); evidence level 4]
- Increasing evidence indicates that such structural attributes, particularly branching patterns and side-chain composition, can influence biological activity, including immune-modulatory effects. [Kerezoudi Evangelia N. (2026); evidence level 4]
- Helicobacter pylori 1 2 3 4 2 Health conditions associated with stomach acid include gastroesophageal reflux disease (GERD), esophagitis, dyspepsia, chronic gastritis, gastric and duodenal ulcers, andinfection. [Teterovska Renāte (2025); evidence level 4]
- A potential alternative approach is the use of herbal medicinal products (HMPs) and food supplements (FSs) for the prevention and treatment of diseases and symptoms associated with increased stomach acid. [Teterovska Renāte (2025); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
For chicory root fiber constipation randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Kerezoudi Evangelia N. (2026). Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults. DOI: 10.20517/mrr.2026.04. PMCID: PMC13246491. PMID: 42272857. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13246491/
- Teterovska Renāte (2025). Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation. DOI: 10.3390/nu17233674. PMCID: PMC12693992. PMID: 41373965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12693992/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 3, 2026 by Migaku Evidence Review
